Earnings Per Share, Basic in USD/shares of PLIANT THERAPEUTICS, INC. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Pliant Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2019 to Q3 2025.
  • Pliant Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.43 USD/shares, a 54.7% increase year-over-year.
  • Pliant Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was -2 USD/shares, a 13.5% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -3.47 USD/shares, a 26.2% decline from 2023.
  • Pliant Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.75 USD/shares, a 6.46% increase from 2022.
  • Pliant Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.94 USD/shares, a 8.49% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2 $0 +$0.52 +54.7% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$3 -$1 +$0.21 +22.8% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$3 -$1 $0 -17.9% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$3 -$1 $0 -20.6% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$3 -$1 $0 -35.7% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$3 -$1 $0 -31.4% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$2 -$1 $0 -16.4% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$2 -$1 +$0.01 +1.45% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$2 -$1 $0 -7.69% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$2 -$1 +$0.12 +14.6% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 -$2 -$1 +$0.11 +14.1% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 -$2 -$1 $0 -1.47% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 -$2 -$1 +$0.10 +13.3% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$3 -$1 $0 -28.1% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 -$2 -$1 $0 -21.9% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$2 -$1 -$1 -656% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024
Q3 2021 -$2 -$1 $0 -59.6% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$1 -$1 +$0.75 +54% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$2 -$1 -$1 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$1 $0 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $0 +$8.06 +94.5% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$1 +$9.43 +87.2% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q3 2019 -$9 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$11 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020

PLIANT THERAPEUTICS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3 -$1 -26.2% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$3 +$0.19 +6.46% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 -$3 $0 -8.49% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$3 -$1 -39% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024
2020 -$2 +$2.27 +53.8% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
2019 -$4 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.